MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Analysis of cortical oscillatory activities may identify a subgroup of Parkinson’s disease patients with suboptimal responses to deep brain stimulation of the subthalamic nucleus

    M. Bočková, M. Lamoš, P. Klimeš, P. Jurák, J. Halámek, S. Goldemundová, M. Baláž, I. Rektor (Brno, Czech Republic)

    Objective: We studied brain oscillations related to DBS in a cognitive and motor task. We hypothesized that the impact of DBS on oscillations related to…
  • 2019 International Congress

    The Dutch Parkinson and Microbiome Study (DUPARM): Gut Microbiome Composition of Treatment-Naïve De Novo Parkinson’s Disease Patients

    J. Boertien, S. Vander Zee, T. van Laar (Groningen, Netherlands)

    Objective: To establish the gut microbiome composition of de novo Parkinson’s disease (PD) patients with no history of dopaminergic medication use. Background: PD is often…
  • 2019 International Congress

    Therapeutic management of complicated Parkinson’s disease: clinical application of the Motor Fluctuation Indices

    R. Bonomo, G. Mostile, A. Nicoletti, M. Zappia (Catania, Italy)

    Objective: To evaluate the usefulness of the Motor Fluctuation Indices to assess clinically relevant change in motor fluctuations in advanced Parkinson’s disease (PD) patients after…
  • 2019 International Congress

    Scene Induced emotion processing in Parkinson’s disease: BOLD-fMRI study

    S. Boujraf, M. Benzagmout, B. Alami, H. Amadou, H. El Hamdaoui, A. Bennani, M. Jaafari, I. Rammouz, M. Maaroufi, D. Boussaoud (Fez, Morocco)

    Objective: The aim of this study was to investigate emotional processing organization in the brain of patients with Parkinson's disease and to explore whether there…
  • 2019 International Congress

    A flowchart algorithm for the neurologist to discuss and attend sexual issues in Parkinson’s disease

    G. Bronner, S. Hassin-Baer, AD. Korczyn, T. Gurevich (Ramat-Gan, Israel)

    Objective: To propose guidelines for neurologists to discuss sexual issues and offer education and practical solutions. Background: Sexual dysfunction (SD) is a common nonmotor symptom…
  • 2019 International Congress

    Constipation with selected prodromal features increases risk of subsequent Parkinson’s Disease

    E. Brown, S. Goldman, K. Albers, S. Vanden Eeden, C. Tanner (San Francisco, CA, USA)

    Objective: To use the electronic medical record (EMR) to understand the independent and joint effects of constipation and other prodromal features on the risk of…
  • 2019 International Congress

    Evaluation of bedside screening tests to detect dysphagia in Parkinson’s disease

    F. Brugger, J. Walch, M. Galovic, S. Hägele-Link, S. Stöckli, M. Müller-Baumberger, G. Kägi (St. Gallen, Switzerland)

    Objective: To evaluate the diagnostic accuracy of bedside screening tests, mainly established for stroke patients, to detect Parkinson's Disease (PD) related dysphagia. Background: Dysphagia is…
  • 2019 International Congress

    Evaluation of dose rate of photobiomodulation (light) therapy in patients with Parkinson’s Disease: Double blind placebo-controlled pilot trial. Is there a dose frequency per week that influences quality of life, mobility and cognition?

    J. Bullock-Saxton, L. Laakso, A. Lehn, F. Read, K. Harm, A. Gosling, S. Hardy, P. Newcombe, A. Nolan, E. Tune (Brisbane, Australia)

    Objective: This assessor- and participant-blinded placebo-controlled pilot study aimed to evaluate the influence on motor outcomes associated with Parkinson’s Disease with different dose application regimens…
  • 2019 International Congress

    Vertebral pain and bone mineral density in women with Parkinson’s disease

    I. Karaban, V. Povoroznyuk, M. Bystrytska, N. Karasevich, N. Grygorieva (Kyiv, Ukraine)

    Objective: This research aimed to study the bone mineral density (BMD) and vertebral pain in females with Parkinson’s disease (PD). Background: PD and systemic osteoporosis…
  • 2019 International Congress

    Peripheral Blood Mononuclear Cells (PBMCs) are Useful Biomarkers of Mitochondrial Dysfunction in Parkinson Disease Patients with Pathogenic Parkin and LRRK2 Mutations

    P. Campbell, J. Harvey, A. Costantini, H. Morris, A. Schapira (London, United Kingdom)

    Objective: To investigate the use of PBMCs as a biomarker of mitochondrial dysfunction in Parkinson disease (PD) patients carrying pathogenic parkin or LRRK2 mutations. Background:…
  • « Previous Page
  • 1
  • …
  • 1272
  • 1273
  • 1274
  • 1275
  • 1276
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley